0 for Windows (StatSoft, Warsaw, Poland) and GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA). Because of asymmetric data distribution (Kolmogorov-Smirnov and Shapiro-Wilk tests), non-parametric tests were used. The results of study and control groups were compared using Mann–Whitney U-test. The correlation between clinical parameters and flow cytometry/real-time PCR results were assessed with Spearman’s Rank GS-1101 mouse Correlation Test. P-values less than 0.05 were considered significant. The graph was prepared in GraphPad Prism 5.0. Children with the MS recognized according to the IDF criteria had significantly higher weight,

BMI, waist/hip circumferences and WHR (P < 0.0001). The analysis of laboratory tests showed no differences in the serum concentrations of uric acid, urea and

creatinine, aminotransferase activity, TSH level and cortisol profile (P > 0.05). Children with MS had higher glycemia and insulinemia before (fasting) and after (2 h) oral glucose tolerance test and higher HOMA [fasting insulin (mU/ml) × fasting glucose (mmol/l)]/22.5 index when compared to control subjects (P < 0.05). Total cholesterol, LDL and triglycerides concentrations were also higher in serum of children with MS, and HDL cholesterol concentration was lower in this group (differences statistically significant). The measurement of blood pressure and 24-h monitoring (ABPM) showed higher systolic and diastolic values in the group Ensartinib of children with MS compared to healthy subjects including mean values, day and night periods and percentile ranges (P < 0.0001). To confirm that CD127low/− cells are T regulatory lymphocytes, we assessed the expression of

FoxP3 and CD127 on CD4+CD25high cells in the peripheral blood from healthy volunteers (N = 30). The percentage of CD4+CD25highCD127low/− cells strongly correlated with the percentage of CD4+CD25highFoxP3+ cells (r = 0.95, P < 0.0001). More than 90% (90-99%) CD4+CD25highCD127low/− cells were FoxP3 positive. Thus, negative or low cell surface expression of CD127 allowed isolation of Tregs from MS and control children for further mRNA studies. To investigate quantitative differences in T regulatory cell populations Amobarbital between children with MS and healthy subjects, we used flow cytometry to assess the percentage of CD4+CD25high, CD4+CD25highFoxP3+ and CD4+CD25highCD127low/− cells in the peripheral blood. The absolute count of white blood cells, lymphocytes and CD4+ cells (both count and percentage) in the peripheral blood was similar in both study and control groups (median: 6.11 versus 6.29 G/l, 2.01 versus 1.93 G/l, 32.5 versus 31.4%, 0.7 versus 0.6 G/l, 35.0 versus 36.0%, respectively, differences statistically not significant). The frequency of CD4+CD25high cells was lower in children with MS compared to control group (1.7 versus 3.7%, P = 0.01).